NCT03259737

Brief Summary

The intention is to study presumed changes in daily practice, probably due to New Guidelines concerning stroke patients. The impression is more frequent measurements of blood pressure, serum glucose, troponin and supplementary computer tomography or magnetic resonance imaging.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2018

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 21, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 24, 2017

Completed
8 months until next milestone

Study Start

First participant enrolled

May 1, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2018

Completed
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

January 5, 2021

Status Verified

December 1, 2020

Enrollment Period

7 months

First QC Date

August 21, 2017

Last Update Submit

December 31, 2020

Conditions

Quality of CareCerebrovascular DisordersHyperglycemiaHypertensionTroponin

Outcome Measures

Primary Outcomes (2)

  • Number of supplementary computer tomography and magnetic resonance imaging of the brain.

    Number

    3 months

  • The number of blood sugar measurements

    Number

    72 hours after admission to hospital

Secondary Outcomes (3)

  • Troponin measurement,

    72 hours

  • Number of blood pressure measurement

    72 hours

  • Transfer to tertiary center

    72 hours

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients \> 18 years, registered with a diagnosis of stroke during 2015 at Innlandet Hospital Trust Lillehammer.

You may qualify if:

  • Patients with a diagnosis of stroke according to ICD 10th revision (code I61 I63 and I64)
  • Hospitalized between January 1 and December 31, 2015

You may not qualify if:

  • Previous hospitalization with a diagnosis of stroke in 2015.
  • Foreigners and patients from other regions of Norway.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Innlandet Hospital Trust Lillehammer

Lillehammer, 2609, Norway

Location

Ellen Bøhmer

Lillehammer, Norway

Location

MeSH Terms

Conditions

Cerebrovascular DisordersHyperglycemiaHypertension

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Ingebjørg Hartz

    Sykehuset Innlandet HF

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
PHD cand med

Study Record Dates

First Submitted

August 21, 2017

First Posted

August 24, 2017

Study Start

May 1, 2018

Primary Completion

November 15, 2018

Study Completion

December 1, 2022

Last Updated

January 5, 2021

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations

NO(2)